News Focus
News Focus
Followers 2
Posts 186
Boards Moderated 0
Alias Born 01/04/2014

Re: Ionthefuture post# 50950

Wednesday, 02/05/2014 1:14:52 PM

Wednesday, February 05, 2014 1:14:52 PM

Post# of 91007
Alright guys, been poking around this Thailand Company's webpage. They are indeed welcoming Intellicell Biosciences soon. a la their website:

"The process we use: IntelliCell™ does not culture, grow, or expand the cells in any way. This is important to clinicians and patients alike. There is no growth serum used in the process, such as growing cells in bovine serum and there are no enzymatic agents in use, such as collagenese. IntelliCell™ thinks that its process results in a minimal manipulation of the originating vascular tissue and the final cellular product. Ultrasound, which has been in clinical use for decades, is the method by which IntelliCell™ is able to obtain the Vascular Fraction Cells.
The IntelliCell™ process also results in much higher cellular yields when compared to other methods in clinical research use today.
It is a same day procedure. This is more convenient for the patient and the clinician." SOURCE: http://www.absolutehealthplus.com/about-us-gid2.aspx

As far as I am aware, THERE HAS BEEN NO PR ABOUT THIS DEVELOPMENT YET.
coupled with Intellicell's announcements of other developments in Thailand:

1) "IntelliCell BioSciences Receives Notice of Its Thailand Patent Application for Its Stem Cell Extraction Technology"

http://finance.yahoo.com/news/intellicell-biosciences-receives-notice-thailand-141500163.html

AND

2) "IntelliCell BioSciences Signs Technology Licensing Agreement with Stem Cells 21 Thailand" (different company than above!)

http://finance.boston.com/boston/news/read/21045211/intellicell_biosciences_signs_technology_licensing_agreement_with_stem_cells_21_thailand

I think it's pretty clear that Dr. Victor has been quite busy, and I think it's now a forgone conclusion that this next PR will be MASSIVE. GLTA, I don't think we'll need it tho :)

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today